Cargando…

Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers

BACKGROUND: Seroprevalence studies are essential to understand the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various technologies, including laboratory assays and point-of-care self-tests, are available for antibody testing. The interpretation of seroprevalence st...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Bethan, Araghi, Marzieh, Moshe, Maya, Gao, He, Bennet, Kimberly, Jenkins, Jordan, Atchison, Christina, Darzi, Ara, Ashby, Deborah, Riley, Steven, Barclay, Wendy, Elliott, Paul, Ward, Helen, Cooke, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522420/
https://www.ncbi.nlm.nih.gov/pubmed/34796246
http://dx.doi.org/10.1093/ofid/ofab496
_version_ 1784585083878899712
author Davies, Bethan
Araghi, Marzieh
Moshe, Maya
Gao, He
Bennet, Kimberly
Jenkins, Jordan
Atchison, Christina
Darzi, Ara
Ashby, Deborah
Riley, Steven
Barclay, Wendy
Elliott, Paul
Ward, Helen
Cooke, Graham
author_facet Davies, Bethan
Araghi, Marzieh
Moshe, Maya
Gao, He
Bennet, Kimberly
Jenkins, Jordan
Atchison, Christina
Darzi, Ara
Ashby, Deborah
Riley, Steven
Barclay, Wendy
Elliott, Paul
Ward, Helen
Cooke, Graham
author_sort Davies, Bethan
collection PubMed
description BACKGROUND: Seroprevalence studies are essential to understand the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various technologies, including laboratory assays and point-of-care self-tests, are available for antibody testing. The interpretation of seroprevalence studies requires comparative data on the performance of antibody tests. METHODS: In June 2020, current and former members of the United Kingdom police forces and fire service performed a self-test lateral flow immunoassay (LFIA), had a nurse-performed LFIA, and provided a venous blood sample for enzyme-linked immunosorbent assay (ELISA). We present the prevalence of antibodies to SARS-CoV-2 and the acceptability and usability of self-test LFIAs, and we determine the sensitivity and specificity of LFIAs compared with laboratory ELISA. RESULTS: In this cohort of 5189 current and former members of the police service and 263 members of the fire service, 7.4% (396 of 5348; 95% confidence interval [CI], 6.7–8.1) were antibody positive. Seroprevalence was 8.9% (95% CI, 6.9–11.4) in those under 40 years, 11.5% (95% CI, 8.8–15.0) in those of nonwhite ethnicity, and 7.8% (95% CI, 7.1–8.7) in those currently working. Self-test LFIA had an acceptability of 97.7% and a usability of 90.0%. There was substantial agreement between within-participant LFIA results (kappa 0.80; 95% CI, 0.77–0.83). The LFIAs had a similar performance: compared with ELISA, sensitivity was 82.1% (95% CI, 77.7–86.0) self-test and 76.4% (95% CI, 71.9–80.5) nurse-performed with specificity of 97.8% (95% CI, 97.3–98.2) and 98.5% (95% CI, 98.1–98.8), respectively. CONCLUSIONS: A greater proportion of this nonhealthcare key worker cohort showed evidence of previous infection with SARS-CoV-2 than the general population at 6.0% (95% CI, 5.8–6.1) after the first wave in England. The high acceptability and usability reported by participants and similar performance of self-test and nurse-performed LFIAs indicate that the self-test LFIA is fit for purpose for home testing in occupational and community prevalence studies.
format Online
Article
Text
id pubmed-8522420
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85224202021-10-20 Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers Davies, Bethan Araghi, Marzieh Moshe, Maya Gao, He Bennet, Kimberly Jenkins, Jordan Atchison, Christina Darzi, Ara Ashby, Deborah Riley, Steven Barclay, Wendy Elliott, Paul Ward, Helen Cooke, Graham Open Forum Infect Dis Major Articles BACKGROUND: Seroprevalence studies are essential to understand the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various technologies, including laboratory assays and point-of-care self-tests, are available for antibody testing. The interpretation of seroprevalence studies requires comparative data on the performance of antibody tests. METHODS: In June 2020, current and former members of the United Kingdom police forces and fire service performed a self-test lateral flow immunoassay (LFIA), had a nurse-performed LFIA, and provided a venous blood sample for enzyme-linked immunosorbent assay (ELISA). We present the prevalence of antibodies to SARS-CoV-2 and the acceptability and usability of self-test LFIAs, and we determine the sensitivity and specificity of LFIAs compared with laboratory ELISA. RESULTS: In this cohort of 5189 current and former members of the police service and 263 members of the fire service, 7.4% (396 of 5348; 95% confidence interval [CI], 6.7–8.1) were antibody positive. Seroprevalence was 8.9% (95% CI, 6.9–11.4) in those under 40 years, 11.5% (95% CI, 8.8–15.0) in those of nonwhite ethnicity, and 7.8% (95% CI, 7.1–8.7) in those currently working. Self-test LFIA had an acceptability of 97.7% and a usability of 90.0%. There was substantial agreement between within-participant LFIA results (kappa 0.80; 95% CI, 0.77–0.83). The LFIAs had a similar performance: compared with ELISA, sensitivity was 82.1% (95% CI, 77.7–86.0) self-test and 76.4% (95% CI, 71.9–80.5) nurse-performed with specificity of 97.8% (95% CI, 97.3–98.2) and 98.5% (95% CI, 98.1–98.8), respectively. CONCLUSIONS: A greater proportion of this nonhealthcare key worker cohort showed evidence of previous infection with SARS-CoV-2 than the general population at 6.0% (95% CI, 5.8–6.1) after the first wave in England. The high acceptability and usability reported by participants and similar performance of self-test and nurse-performed LFIAs indicate that the self-test LFIA is fit for purpose for home testing in occupational and community prevalence studies. Oxford University Press 2021-10-04 /pmc/articles/PMC8522420/ /pubmed/34796246 http://dx.doi.org/10.1093/ofid/ofab496 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Davies, Bethan
Araghi, Marzieh
Moshe, Maya
Gao, He
Bennet, Kimberly
Jenkins, Jordan
Atchison, Christina
Darzi, Ara
Ashby, Deborah
Riley, Steven
Barclay, Wendy
Elliott, Paul
Ward, Helen
Cooke, Graham
Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title_full Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title_fullStr Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title_full_unstemmed Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title_short Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers
title_sort acceptability, usability, and performance of lateral flow immunoassay tests for severe acute respiratory syndrome coronavirus 2 antibodies: react-2 study of self-testing in nonhealthcare key workers
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522420/
https://www.ncbi.nlm.nih.gov/pubmed/34796246
http://dx.doi.org/10.1093/ofid/ofab496
work_keys_str_mv AT daviesbethan acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT araghimarzieh acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT moshemaya acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT gaohe acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT bennetkimberly acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT jenkinsjordan acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT atchisonchristina acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT darziara acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT ashbydeborah acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT rileysteven acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT barclaywendy acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT elliottpaul acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT wardhelen acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers
AT cookegraham acceptabilityusabilityandperformanceoflateralflowimmunoassaytestsforsevereacuterespiratorysyndromecoronavirus2antibodiesreact2studyofselftestinginnonhealthcarekeyworkers